GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications
Lille ; Cambridge ; Zurich ; August 10, 2023 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced the... -Today at 04:11 pm- MarketScreener
France General United States United Kingdom Arunj Sanyal Exchange Commission Uncertainties Of The Company
Source: marketscreener.com